Citation Impact
Citing Papers
Prevention of Type 2 Diabetes Mellitus Through Inhibition of the Renin-Angiotensin System
2004
Metabolic Syndrome: Treatment of Hypertensive Patients
2007
Emerging therapies for chronic kidney disease: what is their role?
2009
Glycosaminoglycan Therapy Prevents TGF-β1 Overexpression and Pathologic Changes in Renal Tissue of Long-Term Diabetic Rats
2000
The metabolic syndrome
2010 Standout
Microalbuminuria and hypertension with focus on type 1 and type 2 diabetes*
2003
Klotho Deficiency Causes Vascular Calcification in Chronic Kidney Disease
2010 Standout
The metabolic syndrome
2005 Standout
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
2017 Standout
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
2013 Standout
Discontinued drugs in 2012: endocrine and metabolic
2013
Microalbuminuria and Endothelial Dysfunction: Emerging Targets for Primary Prevention of End-organ Damage
2006
The glycocalyx—linking albuminuria with renal and cardiovascular disease
2015
Management of Chronic Kidney Disease Patients in the Intensive Care Unit: Mixing Acute and Chronic Illness
2017 Standout
Diabetes and nephropathy
2003
Vitamin D Therapy in Chronic Kidney Disease and End Stage Renal Disease
2011
Pathophysiology of Human Visceral Obesity: An Update
2013 Standout
Diagnosis and Management of the Metabolic Syndrome
2005 Standout
Diabetic Nephropathy: Diagnosis, Prevention, and Treatment
2005 Standout
Evaluation and Management of Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2012 Clinical Practice Guideline
2013 Standout
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Microvascular and Macrovascular Complications of Diabetes
2008 Standout
Oral supplementation with sulodexide inhibits neo-angiogenesis in a rat model of peritoneal perfusion
2011
RAGE Control of Diabetic Nephropathy in a Mouse Model
2006
Mechanisms of Diabetic Complications
2013 Standout
Angiogenesis and Inflammation in Peritoneal Dialysis: The Role of Adipocytes
2017 Standout
The Metabolic Syndrome
2008 Standout
The role of angiotensin II and its receptors in regulation of adipose tissue metabolism and cellularity.
1995
Works of A Okša being referenced
Effects of Long-Term Cholecalciferol Supplementation on Mineral Metabolism and Calciotropic Hormones in Chronic Kidney Disease
2008
Oral Sulodexide Reduces Albuminuria in Microalbuminuric and Macroalbuminuric Type 1 and Type 2 Diabetic Patients
2002
Glycosaminoglycan sulodexide decreases albuminuria in diabetic patients
1997
Effects of Angiotensin-Converting Enzyme Inhibitors on Glucose and Lipid Metabolism in Essential Hypertension
1994
[Celiprolol improves glucose metabolism in essential hypertension].
1998